Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients

Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients

The COVID-19 pandemic has prompted an international effort to develop and repurpose medications and procedures to effectively combat the disease. Several groups have focused on the potential treatment utility of angiotensin-converting-enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs...

Podrobná bibliografie
Hlavní autoři:	Bertsimas, D, Borenstein, A, Mingardi, L, Nohadani, O, Orfanoudaki, A, Stellato, B, Wiberg, H, Sarin, P, Varelmann, DJ, Estrada, V, Macaya, C, Gil, IJN
Médium:	Journal article
Jazyk:	English
Vydáno:	Springer Nature 2021

Podobné jednotky

Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients
Autor: Bertsimas, Dimitris, a další
Vydáno: (2021)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
Autor: S Ravitej, a další
Vydáno: (2022-11-01)

Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
Autor: Jing Ma, a další
Vydáno: (2021-05-01)

ACEIs and ARBs and Their Correlation with COVID-19: A Review
Autor: Yehualashet AS, a další
Vydáno: (2020-09-01)

The Potential Role of ACEi and ARBs in COVID-19; A Perspective
Autor: Ahmad Hammad Hassan
Vydáno: (2020-12-01)

Antihypertensive Therapy by ACEI/ARB Is Associated With Intestinal Flora Alterations and Metabolomic Profiles in Hypertensive Patients
Autor: Ying Dong, a další
Vydáno: (2022-03-01)

MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB
Autor: Martina Weber, a další
Vydáno: (2011-01-01)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)
Autor: D.D. Ivanov, a další
Vydáno: (2021-09-01)

Comparison of Effects of ACEIs and ARBs on Albuminuria and Hyperkalemia in Indonesian Hypertensive Type 2 Diabetes Mellitus Patients
Autor: Putri S. Agustina, a další
Vydáno: (2020-01-01)

Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation
Autor: Zhijie Liu, a další
Vydáno: (2023-06-01)

Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19
Autor: Dong Xiang, a další
Vydáno: (2021-05-01)

Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19
Autor: Seiji Hamada, a další
Vydáno: (2023-07-01)

ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
Autor: Jianqing She, a další
Vydáno: (2021-12-01)

The Effect of Pentoxifylline in Reducing Proteinuria in Patients with Diabetic Nephropathy Treated with ACEI or ARB
Autor: Iranparvar, a další
Vydáno: (2017-10-01)

ALTITUDE halted: Adverse events when aliskiren added to ACEI, ARB therapy
Autor: Santanu Guha, a další
Vydáno: (2012-07-01)

Effects of ACEi and ARB on post-exercise hypotension induced by exercises conducted at different times of day in hypertensive men
Autor: Leandro C. Brito, a další
Vydáno: (2020-11-01)

The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy
Autor: Liping Sun, a další
Vydáno: (2023-03-01)

Effect of antihypertensive agents ACEI/ARB and CCB on hypertensive intracerebral hemorrhage and inflammatory cytokines, serum ferritin, and serum P
Autor: Peiyu Li, a další
Vydáno: (2018-12-01)

A retrospective prognostic evaluation using unsupervised learning in the treatment of COVID-19 patients with hypertension treated with ACEI/ARB drugs
Autor: Liye Ge, a další
Vydáno: (2024-05-01)

Efficacy and safety of tripterygium glycosides combined with ACEI/ARB on diabetic nephropathy: a meta-analysis
Autor: Zhuan’E. Yao, a další
Vydáno: (2025-01-01)

EFFECTIVENESS OF IMMUNOSUPPRESSANTS ALONG WITH ACEI/ARBS IN TREATING PROTEINURIA IN PATIENTS WITH SOLITARY KIDNEY POST NEPHRECTOMY
Autor: Nadeem Azam, a další
Vydáno: (2018-10-01)

Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study
Autor: Ahmed A. Alrashed, a další
Vydáno: (2021-06-01)

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
Autor: Zhe Zhang, a další
Vydáno: (2023-12-01)

Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19.
Autor: Nancy Xurui Huang, a další
Vydáno: (2023-01-01)

Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19
Autor: Nancy Xurui Huang, a další
Vydáno: (2023-01-01)

Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
Autor: Hun-Sung Kim, a další
Vydáno: (2018-12-01)

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
Autor: Mina K. Chung, a další
Vydáno: (2020-08-01)

Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention
Autor: Majd Z, a další
Vydáno: (2022-10-01)

Ensemble machine learning for personalized antihypertensive treatment
Autor: Bertsimas, D, a další
Vydáno: (2021)

[ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study].
Autor: Liu, J, a další
Vydáno: (2013)

Safety of ACEI/ARB use in the early (<3 months) post kidney transplant period: a systematic review and meta-analysis
Autor: Dahai Fu, a další
Vydáno: (2024-12-01)

Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE
Autor: Dorcas Beaton, a další
Vydáno: (2023-11-01)

Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis
Autor: Ying Tan, a další
Vydáno: (2024-01-01)

Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
Autor: Ruxin Wang, a další
Vydáno: (2022-12-01)

ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking
Autor: Chidinma L. Onweni, a další
Vydáno: (2020-07-01)

Ensemble machine learning for personalized antihypertensive treatment
Autor: Bertsimas, Dimitris, a další
Vydáno: (2022)

Clinical effect of milk vetch injection combined with ACEI or ARB in early diabetic nephropathy treatment: a systematic review and meta-analysis
Autor: Xiao-yu ZONG, a další
Vydáno: (2022-09-01)

Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.
Autor: Jiunn-Horng Kang, a další
Vydáno: (2018-01-01)

Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome
Autor: Yue Zhang, a další
Vydáno: (2020-04-01)

ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Learning
Autor: Boshen Yang, a další
Vydáno: (2022-01-01)